Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) A… is a federal NONE award for Department of Health and Human Services (HHS) held by Albert B. Sabin Vaccine Institute, Inc.. (the). Estimated value $163.1M ($163.1M obligated). Current period of performance ends Sep 30, 2030 (potential Dec 27, 2037). Last award drew 1 bidder. Place of performance: WASHINGTON, DC. Related solicitation BAA18100SOL00003.
THE SCOPE OF THE PROPOSED PROGRAM INCLUDES MANUFACTURE OF SABIN?S SUDAN EBOLAVIRUS VACCINE (BULK DRUG SUBSTANCE (BDS) AND FINAL DRUG PRODUCT (FDP)) TO PROVIDE DOSES THAT MAY BE USED IN THE EVENT OF AN OUTBREAK SCENARIO. THE PROPOSED EFFORT WILL UTILI
Recompete timing
PublicCurrent PoP ends Sep 30, 2030 (1468 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 30, 2029.
Want the durability read on 75A50123C00010? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordAlbert B. Sabin Vaccine Institute, Inc.. (the) — $318.8M obligated across 3 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75A50123C00010?
75A50123C00010 (BDS SCOPE proposed program includes) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $163.1M, currently held by Albert B. Sabin Vaccine Institute, Inc.. (the). Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75A50123C00010?
Barda - Aspr / Daappo / Barda Dcma awarded 75A50123C00010 to Albert B. Sabin Vaccine Institute, Inc.. (the).
Who is the incumbent on 75A50123C00010?
Albert B. Sabin Vaccine Institute, Inc.. (the) is the incumbent with $318.8M across 3 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2030.
When does Albert B. Sabin Vaccine Institute, Inc.. (the)’s 75A50123C00010 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2030. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75A50123C00010? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.